Drug Trial Radar · NCT00325195
Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
Last checked: Nov 20, 2026Latest source record: Feb 28, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
225
Actual
Start
May 2006
Primary completion
Oct 2007
Study completion Dec 2007
Sponsor
- Lead sponsor
- Savient PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 12, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
These are two replicate studies to evaluate the safety and efficacy of PEG (polyethylene glycol)-uricase in controlling the uric acid level in symptomatic gout patients with high uric acid levels who are unable to take standard gout therapies, or for whom those therapies have been unsuccessful in controlling their uric acid level.
Conditions
- Gout
Interventions
placeboOther
placebo by intravenous infusion every 2 weeks
pegloticaseBiological
8 mg pegloticase by intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma Uric Acid (PUA) ResponderTime frame: Months 3 and 6
Locations
56 sites in 3 countries. Site status is shown where the registry gives one.
UAB Arthritis Clinical Intervention Program
Birmingham, Alabama
University of Arizona Arthritis Center
Tucson, Arizona
NEA Clinic
Jonesboro, Arkansas
UCSD Rheumatology Division
La Jolla, California
Kaiser Permanente Medical Center, Clinical Trials Unit
San Francisco, California
Pacific Arthritis Center Medical Group
Santa Maria, California
E. Robert Harris Medical Corporation
Whittier, California
Agilence Arthritis & Osteoporosis Medical Center
Whittier, California
Arthritis Associates & Osteoporosis Center of Colorado Springs
Colorado Springs, Colorado
Veterans Affairs Medical Center
Washington D.C., District of Columbia
Arthritis & Rheumatic Disease Specialties
Aventura, Florida
Malcom Randall VA Medical Center
Gainesville, Florida
Horizon Institute for Clinical Research
Hollywood, Florida
Ocala Rheumatology Research Center
Ocala, Florida
Arthritis & Osteoporosis Treatment Center, PA
Orange Park, Florida
St. Petersburg Arthritis Center
St. Petersburg, Florida
Idaho Arthritis & Osteoporosis Center
Boise, Idaho
Institute of Arthritis Research
Idaho Falls, Idaho
The University of Chicago
Chicago, Illinois
Graves Gilbert Clinic
Bowling Green, Kentucky
Peter A. Holt, M.D.
Baltimore, Maryland
Malamet & Klein, MD, PA
Hagerstown, Maryland
The Center for Rheumatology and Bone Research
Wheaton, Maryland
Fallon Clinic, Inc
Worcester, Massachusetts
Michigan Arthritis Research Center
Brighton, Michigan
Justus J. Fiechtner, MD, PC
Lansing, Michigan
Mayo Clinic
Rochester, Minnesota
CentraCare Clinic
Saint Cloud, Minnesota
Rheumatology Associates of North Jersey
Teaneck, New Jersey
Mount Sinai Medical Center
New York, New York
Duke University Medical Center
Durham, North Carolina
Brody School of Medicine, East Carolina University
Greenville, North Carolina
Physicians East, P.A.
Greenville, North Carolina
Carolina Atthritis Associates
Wilmington, North Carolina
New Horizons Clinical Research
Cincinnati, Ohio
The Cleveland Clinic Foundation
Cleveland, Ohio
The Ohio State University
Columbus, Ohio
STAT Research, Inc.
Dayton, Ohio
David R. Mandel, MD, Inc.
Mayfield Village, Ohio
Health Research of Oklahoma
Oklahoma City, Oklahoma
Showing 40 of 56 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.